Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma

AIMS: To date, curative resection remains to be the most optimal therapeutic choice of hepatocellular carcinoma (HCC), though the overall survival (OS) remains extremely unsatisfactory. To better manage the HCC patients, we evaluated the prognosis predicting values of apolipoprotein B (ApoB) and low...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Onco Targets Ther
Главные авторы: Yan, Xiaotong, Yao, Mingjie, Wen, Xiajie, Zhu, Yiwei, Zhao, Erjiang, Qian, Xiangjun, Chen, Xiangmei, Lu, Weiquan, Lv, Quanjun, Zhang, Ling, Lu, Fengmin
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2019
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420103/
https://ncbi.nlm.nih.gov/pubmed/30881047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S192631
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы